Ikarian Capital’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
2021
Q1
$1.44M Buy
2020
Q4
$398K Buy
2020
Q3
Sell
2020
Q2
$29K Hold
2020
Q1
$46K Hold
2019
Q4
$38K Buy